Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 02, 12:52
Statera BioPharma Shareholders Equity (Quarterly): -10.24M for Sept. 30, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | -10.24M |
| June 30, 2022 | -6.989M |
| March 31, 2022 | -2.485M |
| December 31, 2021 | -1.568M |
| Date | Value |
|---|---|
| September 30, 2021 | 74.12M |
| June 30, 2021 | -3.619M |
| March 31, 2021 | -4.672M |
| December 31, 2020 | -3.656M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.24M
Minimum
Sep 2022
74.12M
Maximum
Sep 2021
5.112M
Average
-3.637M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cantabio Pharmaceuticals Inc | -1.889M |
| Q BioMed Inc | -6.441M |
| NVN Liquidation Inc | -2.828M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | -9.452M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.75M |
| Total Liabilities (Quarterly) | 22.92M |